LSP V Cooperatieve U.A. 13D/13G Filings for Eloxx Pharmaceuticals, Inc. (ELOX)

LSP V Cooperatieve U.A. 13D and 13G filings for Eloxx Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-02-03
4:16 pm
Unchanged		 3021-12-31 13D Eloxx Pharmaceuticals, Inc.
ELOX		 LSP V Cooperatieve U.A. 73,842
3.400%		 0
(Unchanged)		 Filing